Our goal is to very quickly take data from
The MMRF CoMMpass Study SM and move from
a hypothesis to a fact to a clinical pathway.
— Kathy Giusti | Founder MMRF, Co-Chair,
HBS Kraft Precision Medicine Accelerator
”
MMRF FOUNDER & CLIFTON LEAF
DISCUSS PRECISION MEDICINE
The MMRF recently held a Leadership Circle Summit, wherein Kathy Giusti (KG) sat down with Clifton Leaf (CL),
Editor-in-Chief of Fortune magazine and a longtime friend of the Foundation, for a “fireside chat.” The two discussed the
promise of precision medicine in finding cures for patients with multiple myeloma and other cancers.
An excerpt from their conversation has been edited for clarity and brevity.
CL: How is the MMRF CoMMpass
Study SM advancing precision medicine?
KG: Our vision at the MMRF